Johnson & Johnson (JNJ) Overview
- 30 Mar 2026: Period ending 28 Jun 2026; Estimate (m); Actual 2.27; Beat / miss (m).
- 29 Dec 2025: Period ending 29 Mar 2026; Estimate (m); Actual 2.14; Beat / miss (m).
- 30 Jun 2025: Period ending 28 Sept 2025; Estimate (m); Actual 2.12; Beat / miss (m).
- 31 Mar 2025: Period ending 29 Jun 2025; Estimate (m); Actual 2.29; Beat / miss (m).
Stock Price Chart
View more →Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
- Last close
- $276.25
- Previous close
- $267.57
- Change
- $8.68
- Change (%)
- 3.24%
- Close date
- 2026-11-06
- Previous close date
- 2026-09-29
- Open
- (m)
- Day high
- (m)
- Day low
- (m)
- Last session volume
- (m)
- Last session value
- (m)
- Currency
- USD
- Price basis
- split-adjusted
- Volume basis
- (m)
Performance
View more →Cumulative total returns · 2026-09-29
YTD
- JNJ
- +31.39%
- S&P 500
- (m)
1 year
- JNJ
- +50.67%
- S&P 500
- (m)
3 years
- JNJ
- +87.11%
- S&P 500
- (m)
5 years
- JNJ
- +87.61%
- S&P 500
- (m)
Earnings trends
View more →Earnings per share
USD / share · As filed
28 Jun 2026 ○ Estimate (m) ● Actual 2.27
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 30 Mar 2026 | 28 Jun 2026 | (m) | 2.27 | (m) | (m) |
| 29 Dec 2025 | 29 Mar 2026 | (m) | 2.14 | (m) | (m) |
| 30 Jun 2025 | 28 Sept 2025 | (m) | 2.12 | (m) | (m) |
| 31 Mar 2025 | 29 Jun 2025 | (m) | 2.29 | (m) | (m) |
| 30 Dec 2024 | 30 Mar 2025 | (m) | 4.54 | (m) | (m) |
28 Dec 2025 ○ Estimate (m) ● Actual 11.03
Comparison details
| Period start | Period ending | Estimate | Actual | Beat / miss | Report date |
|---|---|---|---|---|---|
| 30 Dec 2024 | 28 Dec 2025 | (m) | 11.03 | (m) | (m) |
| 1 Jan 2024 | 29 Dec 2024 | (m) | 5.79 | (m) | (m) |
| 2 Jan 2023 | 31 Dec 2023 | (m) | 13.72 | (m) | (m) |
| 3 Jan 2022 | 1 Jan 2023 | (m) | 6.73 | (m) | (m) |
| 4 Jan 2021 | 2 Jan 2022 | (m) | 7.81 | (m) | (m) |
(m)
Revenue vs. Earnings
USD
28 Jun 2026 ■ Revenue 25.31B ■ Earnings 5.53B — Profit margin 21.86%
28 Dec 2025 ■ Revenue 94.19B ■ Earnings 26.80B — Profit margin 28.46%
Analyst insights
View more →| Ratings | Buy | Hold | Sell | Other ratings | Last Close | Average Target | Upside | High Target | Low Target |
|---|---|---|---|---|---|---|---|---|---|
| (m) | (m) | (m) | (m) | (m) | $276.25 | (m) | (m) | (m) | (m) |
Recent news
View more →(m)
YouTube videos mentioning JNJ
View more →(m)
Statistics
View more →Retained observations as of 2026-11-11; financial period ending (m).
- Forward P/E
- (m)
- PEG ratio · 5-year expected
- (m)
- Shares held by insiders
- (m)
- Insider transactions · change (%)
- (m)
- Shares held by institutions
- (m)
- Institutional transactions · change (%)
- (m)
- Diluted EPS · 12 month
- (m)
- EPS estimate · next quarter
- (m)
- EPS estimate · next year
- (m)
- EPS growth · current annual estimate
- (m)
- EPS growth · next annual estimate
- (m)
- EPS growth · next 5 years expected
- (m)
- EPS growth · past 3 years annualized
- (m)
- EPS growth · past 5 years annualized
- (m)
- EPS change · 12 months vs prior year
- (m)
- EPS change · latest quarter vs previous quarter
- (m)
- Latest earnings report date
- (m)
- EPS surprise · latest reported quarter
- (m)
- Net income · 12 month
- (m)
- Profit margin
- (m)
- Return on assets · 12 month
- (m)
- Stock compensation expense · all employees · 12 months
- (m)
- Index membership
- (m)
- Employees
- 138.20K
- IPO date
- (m)
- Options available
- (m)
- Shortable
- (m)
- Analyst recommendation
- (m)
- Analyst target price
- (m)
- Price volatility · week
- (m)
- Price volatility · month
- (m)
- Average true range · 14 sessions
- (m)
- Relative strength index · 14 sessions
- (m)
- Relative volume
- (m)
- Average daily volume
- 6.30M
- Latest session volume
- (m)
- Last session value
- (m)
- 30 days ago session value
- (m)
- 1 year ago session value
- (m)
- Number of trades
- (m)
- Total return · week
- -0.63%*
- Total return · month
- -0.15%*
- Total return · quarter
- 4.03%*
- Total return · half year
- 12.49%*
- Total return · year to date
- 31.39%*
- Total return · 1 year
- 50.67%*
- Total return · 3 years
- 87.11%*
- Total return · 5 years
- 87.61%*
- Market cap
- (m)
- Book value per share · latest quarter
- (m)
- Price / cash · latest quarter
- (m)
- Enterprise value
- (m)
- Enterprise value / revenue
- (m)
- Enterprise value / EBITDA
- (m)
- Dividend · 12 months per share
- (m)
- Dividend ex-date
- (m)
- Next dividend ex-date
- (m)
- Next dividend amount per share
- (m)
- Dividend growth · 3 years annualized
- (m)
- Dividend growth · 5 years annualized
- (m)
- Revenue · 12 month
- (m)
- Revenue growth · past 3 years annualized
- (m)
- Revenue growth · past 5 years annualized
- (m)
- Revenue change · 12 months vs prior year
- (m)
- Revenue change · latest quarter vs previous quarter
- (m)
- Revenue surprise · latest reported quarter
- (m)
- Levered free cash flow · 12 month
- (m)
- Debt / equity · latest quarter
- (m)
- Long-term debt / equity · latest quarter
- (m)
- Return on equity · 12 month
- (m)
- Return on invested capital · 12 months
- (m)
- Previous close
- (m)
- Latest closing price
- (m)
- Latest session change (%)
- (m)
- 52-week high
- (m)
- 52-week low
- (m)
- Price vs 20-session moving average
- (m)
- Price vs 50-session moving average
- (m)
- Price vs 200-session moving average
- (m)
- Float shares
- (m)
- Short float (%)
- (m)
- Short ratio (days to cover)
- (m)
- Short interest (shares)
- (m)
Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.
Holders breakdown
View more →| Breakdown | Ownership |
|---|---|
| (m) | Shares held by all insiders |
| (m) | Shares held by institutions |
| (m) | Float held by institutions |
| (m) | Institutions holding shares |
Other holders
(m)
Insider holders
(m)
Top institutional holders
(m)
Top mutual fund holders
(m)
Johnson & Johnson Overview
View more →(m)
(m)
- SEC CIK
- 200406
- Industry (SIC)
- 2834 Pharmaceutical Preparations
- Country of operation
- United States
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, New Jersey, 08933, United States
- Fiscal year end
- 0103
- Phone
- 732-524-2455
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |